217 related articles for article (PubMed ID: 31117164)
1. Oral Administration of
Song JM; Woo BH; Lee JH; Yoon S; Cho Y; Kim YD; Park HR
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117164
[TBL] [Abstract][Full Text] [Related]
2. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential.
Woo BH; Kim DJ; Choi JI; Kim SJ; Park BS; Song JM; Lee JH; Park HR
Oncotarget; 2017 Jul; 8(29):46981-46992. PubMed ID: 28388583
[TBL] [Abstract][Full Text] [Related]
3. Serum Levels of Interleukin-6 and Titers of Antibodies Against
Park DG; Woo BH; Lee BJ; Yoon S; Cho Y; Kim YD; Park HR; Song JM
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167516
[TBL] [Abstract][Full Text] [Related]
4. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties.
Ha NH; Woo BH; Kim DJ; Ha ES; Choi JI; Kim SJ; Park BS; Lee JH; Park HR
Tumour Biol; 2015 Dec; 36(12):9947-60. PubMed ID: 26178482
[TBL] [Abstract][Full Text] [Related]
5. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs.
Ha NH; Park DG; Woo BH; Kim DJ; Choi JI; Park BS; Kim YD; Lee JH; Park HR
Cytokine; 2016 Oct; 86():64-72. PubMed ID: 27468958
[TBL] [Abstract][Full Text] [Related]
6. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
[TBL] [Abstract][Full Text] [Related]
7. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review.
Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM
J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis suppresses oral squamous cell carcinoma progression by inhibiting MUC1 expression and remodeling the tumor microenvironment.
Lan Z; Zou KL; Cui H; Zhao YY; Yu GT
Mol Oncol; 2024 May; 18(5):1174-1188. PubMed ID: 37666495
[TBL] [Abstract][Full Text] [Related]
9.
Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L
J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on the relationship between Porphyromonas gingivalis and oral squamous cell carcinoma].
Wu-chao W; Yafei W; Lei Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Dec; 33(6):651-5. PubMed ID: 27051963
[TBL] [Abstract][Full Text] [Related]
11. T cell response mediated by myeloid cell-derived IL-12 is responsible for Porphyromonas gingivalis-induced periodontitis in IL-10-deficient mice.
Sasaki H; Suzuki N; Kent R; Kawashima N; Takeda J; Stashenko P
J Immunol; 2008 May; 180(9):6193-8. PubMed ID: 18424741
[TBL] [Abstract][Full Text] [Related]
12. Possible role of
Olsen I; Yilmaz Ö
J Oral Microbiol; 2019; 11(1):1563410. PubMed ID: 30671195
[TBL] [Abstract][Full Text] [Related]
13. sRNA23392 packaged by Porphyromonas gingivalis outer membrane vesicles promotes oral squamous cell carcinomas migration and invasion by targeting desmocollin-2.
Liu D; Liu S; Liu J; Miao L; Zhang S; Pan Y
Mol Oral Microbiol; 2021 Jun; 36(3):182-191. PubMed ID: 33764008
[TBL] [Abstract][Full Text] [Related]
14.
Wen L; Mu W; Lu H; Wang X; Fang J; Jia Y; Li Q; Wang D; Wen S; Guo J; Dai W; Ren X; Cui J; Zeng G; Gao J; Wang Z; Cheng B
J Dent Res; 2020 Jun; 99(6):666-675. PubMed ID: 32298192
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by stimulating the release of neutrophil extracellular traps in the tumor immune microenvironment.
Guo ZC; Jing SL; Jia XY; Elayah SA; Xie LY; Cui H; Tu JB; Na SJ
Inflamm Res; 2024 May; 73(5):693-705. PubMed ID: 38150024
[TBL] [Abstract][Full Text] [Related]
16. Persistent Exposure to
Geng F; Liu J; Guo Y; Li C; Wang H; Wang H; Zhao H; Pan Y
Front Cell Infect Microbiol; 2017; 7():57. PubMed ID: 28286742
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
[TBL] [Abstract][Full Text] [Related]
18. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin.
Kamarajan P; Ateia I; Shin JM; Fenno JC; Le C; Zhan L; Chang A; Darveau R; Kapila YL
PLoS Pathog; 2020 Oct; 16(10):e1008881. PubMed ID: 33002094
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma.
Chen MF; Lu MS; Hsieh CC; Chen WC
Cell Oncol (Dordr); 2021 Apr; 44(2):373-384. PubMed ID: 33201403
[TBL] [Abstract][Full Text] [Related]
20. TLR2 promoter hypermethylation creates innate immune dysbiosis.
Benakanakere M; Abdolhosseini M; Hosur K; Finoti LS; Kinane DF
J Dent Res; 2015 Jan; 94(1):183-91. PubMed ID: 25389002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]